go to main content
Radboudumc and partners Spin-off companies
Results (27)

Filter results

Aiosyn

Our solution helps pathologists to deliver faster and better pathological examinations anywhere in the world, anytime.

anDREa

anDREa develops, distributes and promotes the Digital Research Environment Azure DRE.

Ardim BV

By combining AI algorithms with smartphone applications we aim to lighten the workload for healthcare professionals by providing the right diagnosis at the right place.

Astherna

An RNA therapy company focused on realizing treatment for Stargardt disease, an inherited progressive retinal disorder.

ATRO Medical BV

The focus of ATRO Medical BV is to develop and commercialize an anatomical shaped prostheses for joint injuries.

Aurelius Therapeutics BV

Aurelius Therapeutics is bravely developing novel radioligand therapies (RLTs) comprising highly selective tumour-targeting molecules and potent tumour-killing radioisotopes.

Beter Verwijs

We are the first nationwide referral platform in the Netherlands that enables healthcare professionals to connect patients with reimbursed lifestyle and social support services.

BIOTRIP

Biotech incubator to deliver the vaccines and immunotherapies of the future.

CardiacBooster

A simple device that mechanically supports the heart in that first critical phase, in order to increase the chances of survival.

Cell4Pharma

Cell4Pharma tackles your ADME-tox issues based upon our ciPTEC platforms.

Cenya Imaging

Cenya is developing imaging agents - BEACONS - to quantify cell therapies over extended periods of time.

Enzyre BV

Near Patient Diagnostics Focused on Blood Coagulation.

Exolumen

We are pioneering projected augmented reality (PAR) to help surgeons see what lies beneath the skin, before making the first incision.

INBORN

We develop nanoparticle-based gels for the treatment of chronic bone infections such as osteomyelitis.

Khondrion

Khondrion is a pharmaceutical company focusing on the discovering and development of innovative drugs to treat Mitochondrial disease.

Philikos

We develop antibody-based therapies that selectively eliminate overactive immune cells, aiming to restore immune balance without the risks of full immune ablation.

Predica Diagnostics BV

Predica Diagnostics B.V. is active in the field of diagnostics, prognostics and prediction of treatment response in oncology.

QM Diagnostics

QM Diagnostics is a diagnostic microbiological laboratory for health monitoring of small laboratory animals, in particular rodents, rabbits and fish.

Radboud Translational Medicine

Radboud Translational Medicine has a state-of-the-art cyclotron facility for the development and production of radiopharmaceuticals.

Screenpoint Medical

ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis.

Simmunext Biotherapeutics BV

Simmunext has developed an innovative approach to create polymers which can act as artificial antigen-presenting cells to stimulate the immune system to obtain a therapeutic response.

SMB Life Sciences

SMB Facilities & Support boosts open innovation by providing state-of-the-art and top-quality facilities, together with coaching and support of start-ups and SME’s.

Soteria Medical

Soteria Medical has developed a unique new robot, which allows for fast and precise in-bore targeting of tumor suspicious areas within the prostate gland, based on MR images.

SPL Medical

SPL Medical is strongly committed to improving MRI imaging and so enabling a much more precise, effective and patient-friendly diagnosis of cancer metastasis.

Thirona

Thirona develops computer algorithms for analyzing medical imaging data. Currently, Thirona focuses on quantitative analysis of thoracic CT scans.

TropIQ

TropIQ Health Sciences operates a technology platform for the discovery and development of molecules to combat insect-borne infectious diseases.

Xheal Diagnostics

Xheal Diagnostics has developed the Modular Breath Sampler. A non-invasive sampling device to sample the lower respiratory tract.

What we do

collaboration opportunities
contact
news